Ronald Harold Wilfred Cooper - 19 Jan 2023 Form 4 Insider Report for ALBIREO PHARMA, INC.

Role
President and CEO, Director
Signature
/s/ Jason Duncan, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
19 Jan 2023
Net transactions value
$0
Form type
4
Filing time
25 Jan 2023, 19:11:44 UTC
Previous filing
09 Jan 2023
Next filing
23 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Award $0 +195,000 +339% $0.000000 252,444 19 Jan 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 19, 2024, with the remainder vesting in equal installments every three months thereafter beginning on April 19, 2024 and ending on January 19, 2027.
F2 Represents 33,094 shares of common stock and 219,350 restricted stock units.